WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia.
/in Acute Leukemia, Dendritic Cells, International Publications /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2506)[Dendritic cell-based therapeutic vaccination for acute myeloid leukemia]
/in Acute Leukemia, Dendritic Cells, International Publications /von 2012-06-01 / Bull Cancer 2012 Jun;99(6):635-42Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo
/in Acute Leukemia, International Publications, Newcastle Disease Virus /von 2011-11-30 / Leuk. Res. 2012 May;36(5):634-45Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells
/in Acute Leukemia, Dendritic Cells, International Publications /von 2011-08-04 / Ger Med Sci 2011;9:Doc18[Roles of Newcastle disease virus in human acute monocytic leukemia in vitro and in vivo]
/in Acute Leukemia, International Publications, Newcastle Disease Virus /von 2011-02-01 / Zhongguo Dang Dai Er Ke Za Zhi 2011 Feb;13(2):149-52Induction of complete and molecular remissions in acute myeloid leukemia by Wilms‘ tumor 1 antigen-targeted dendritic cell vaccination
/in Acute Leukemia, Dendritic Cells, International Publications /von 2010-07-14 / Proc. Natl. Acad. Sci. U.S.A. 2010 Aug;107(31):13824-9Immunotherapy of acute myeloid leukemia: current approaches
/in Acute Leukemia, International Publications /von 2009-03-16 / Oncologist 2009 Mar;14(3):240-52Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response
/in Acute Leukemia, International Publications /von 2009-02-19 / Cancer Immunol. Immunother. 2009 Oct;58(10):1669-77Immunotherapy in acute leukemia
/in Acute Leukemia, International Publications /von 2009-01-01 / Semin. Hematol. 2009 Jan;46(1):89-99IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de